Physician

Jeffrey K. Bahr, M.D.

According to 2025 Medicare claims, Jeffrey Bahr, M.D. (NPI: 1770511453) practices internal medicine in the Milwaukee-Waukesha, WI market, with the plurality of this provider's patient population coming from Milwaukee, WI. This provider's primary affiliated billing organization is AURORA MEDICAL GROUP, INC. (NPI: 1427271378; TIN: 391678306) and primary practice location at 53209-2042. Bahr is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Bahr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 67,125 traditional Medicare patients, billed 206,851 HCPCS/CPT codes, and received $2,011,946 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 6,189 prescription claims across 4,986 beneficiaries totaling $1,215,947 in drug costs, led by Arexvy (Rsvpref3 Antigen/As01e/Pf). 2018 DME data shows 14 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $96,161 and ending at $2,011,946. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $499,974 to $1,215,947. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,922 to $1,069.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	332	2,113	$96,161
2016	219	1,398	$36,191
2017	70,898	303,992	$1,673,668
2018	73,898	319,003	$1,645,336
2019	76,456	323,307	$1,577,141
2020	67,578	253,301	$1,317,119
2021	122,373	443,720	$5,809,219
2022	74,905	314,674	$2,540,655
2023	70,384	270,038	$3,111,118
2024	67,125	206,851	$2,011,946

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	527	8,471	$499,974
2016	461	6,363	$414,644
2017	218	1,118	$63,774
2018	56	218	$21,538
2019	318	416	$57,994
2020	342	450	$59,122
2021	378	501	$67,858
2022	2,213	2,923	$451,707
2023	6,249	8,125	$1,759,447
2024	4,986	6,189	$1,215,947

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	97	321	$4,456
2016	80	279	$6,473
2017	29	74	$997
2018	N/R	14	$373
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	5,492	7,281	$10
36415	Insertion of needle into vein for collection of blood sample	66,311	164,063	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	2,402	3,582	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	6,442	9,543	$7
81001	Manual urinalysis test with examination using microscope, automated	2,377	3,388	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Arexvy	Rsvpref3 Antigen/As01e/Pf	2,135	2,318	$632,516
Shingrix	Varicella-Zoster Ge/As01b/Pf	2,210	2,491	$459,460
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	1,355	1,422	$85,536
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	37	37	$11,146
Naloxone Hcl	Naloxone Hcl	110	1,374	$7,293

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jeffrey K. Bahr, M.D.?

Tedicare shows public-source Medicare data for Jeffrey K. Bahr, M.D. (NPI 1770511453), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey K. Bahr, M.D. have ACO affiliation data?

Jeffrey K. Bahr, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Jeffrey K. Bahr, M.D.?

Jeffrey K. Bahr, M.D. is linked to AURORA MEDICAL GROUP, INC. (billing NPI 1427271378) in the available physician profile data.

Does Jeffrey K. Bahr, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.